APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Influenza Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Swine Influenza Vaccines Industry Growth and Trends Forecast to 2032

29 December 2025103 pages

Choose your research edition.

Industry ResearchSwine Influenza Vaccines Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Influenza Vaccines Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Swine Influenza Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Influenza Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Influenza Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Swine Influenza Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Swine Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Swine Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Swine Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Swine Influenza Vaccines include Boehringer Ingelheim, CAHIC, Ceva, DHN, Green Cross Veterinary, Hipra, MSD Animal Health (Merck), Ringpu Biology and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Swine Influenza Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Swine Influenza Vaccines market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Swine Influenza Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Swine Influenza Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Swine Influenza Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Swine Influenza Vaccines Market by Company

Boehringer Ingelheim

CAHIC

Ceva

DHN

Green Cross Veterinary

Hipra

MSD Animal Health (Merck)

Ringpu Biology

Zoetis

Chengdu TECBOND

Swine Influenza Vaccines Segment by Type

Live Vaccines

Killed Vaccines

Swine Influenza Vaccines Segment by Application

Commodity Pig

Breeding Pig

Swine Influenza Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Influenza Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Swine Influenza Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Swine Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Live Vaccines Table 2. Major Company of Killed Vaccines Table 3. Global Swine Influenza Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Swine Influenza Vaccines Sales by Type (2021-2026) & (M Units) Table 5. Global Swine Influenza Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Swine Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Swine Influenza Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Swine Influenza Vaccines Price by Type (2021-2026) & (US$/Unit) Table 9. Global Swine Influenza Vaccines Sales by Type (2027-2032) & (M Units) Table 10. Global Swine Influenza Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Swine Influenza Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Swine Influenza Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Swine Influenza Vaccines Price by Type (2027-2032) & (US$/Unit) Table 14. North America Swine Influenza Vaccines Sales by Type (2021-2026) & (M Units) Table 15. North America Swine Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Swine Influenza Vaccines Sales by Type (2021-2026) & (M Units) Table 17. Europe Swine Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Swine Influenza Vaccines Sales by Type (2021-2026) & (M Units) Table 19. Asia-Pacific Swine Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Swine Influenza Vaccines Sales by Type (2021-2026) & (M Units) Table 21. Latin America Swine Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Swine Influenza Vaccines Sales by Type (2021-2026) & (M Units) Table 23. Middle East and Africa Swine Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Swine Influenza Vaccines Industry Trends Table 25. Swine Influenza Vaccines Industry Drivers Table 26. Swine Influenza Vaccines Industry Opportunities and Challenges Table 27. Swine Influenza Vaccines Industry Restraints Table 28. Global Swine Influenza Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Swine Influenza Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Swine Influenza Vaccines Sales by Company (2021-2026) & (M Units) Table 31. Global Swine Influenza Vaccines Sales Share by Company (2021-2026) Table 32. Global Swine Influenza Vaccines Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Swine Influenza Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Swine Influenza Vaccines Major Company Production Sites and Headquarters Table 35. Global Swine Influenza Vaccines Company, Product Type & Application Table 36. Global Swine Influenza Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Swine Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Swine Influenza Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Swine Influenza Vaccines Sales by Region (2021-2026) & (M Units) Table 41. Global Swine Influenza Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Swine Influenza Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Swine Influenza Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Swine Influenza Vaccines Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Swine Influenza Vaccines Sales by Region (2027-2032) & (M Units) Table 46. Global Swine Influenza Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Swine Influenza Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Swine Influenza Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Swine Influenza Vaccines Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Swine Influenza Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Swine Influenza Vaccines Sales by Application (2021-2026) & (M Units) Table 52. Global Swine Influenza Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Swine Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Swine Influenza Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Swine Influenza Vaccines Price by Application (2021-2026) & (US$/Unit) Table 56. Global Swine Influenza Vaccines Sales by Application (2027-2032) & (M Units) Table 57. Global Swine Influenza Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Swine Influenza Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Swine Influenza Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Swine Influenza Vaccines Price by Application (2027-2032) & (US$/Unit) Table 61. North America Swine Influenza Vaccines Sales by Application (2021-2026) & (M Units) Table 62. North America Swine Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Swine Influenza Vaccines Sales by Application (2021-2026) & (M Units) Table 64. Europe Swine Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Swine Influenza Vaccines Sales by Application (2021-2026) & (M Units) Table 66. Asia-Pacific Swine Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Swine Influenza Vaccines Sales by Application (2021-2026) & (M Units) Table 68. Latin America Swine Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Swine Influenza Vaccines Sales by Application (2021-2026) & (M Units) Table 70. Middle East and Africa Swine Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Boehringer Ingelheim Company Information Table 72. Boehringer Ingelheim Business Overview Table 73. Boehringer Ingelheim Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Boehringer Ingelheim Swine Influenza Vaccines Product Portfolio Table 75. Boehringer Ingelheim Recent Development Table 76. CAHIC Company Information Table 77. CAHIC Business Overview Table 78. CAHIC Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. CAHIC Swine Influenza Vaccines Product Portfolio Table 80. CAHIC Recent Development Table 81. Ceva Company Information Table 82. Ceva Business Overview Table 83. Ceva Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Ceva Swine Influenza Vaccines Product Portfolio Table 85. Ceva Recent Development Table 86. DHN Company Information Table 87. DHN Business Overview Table 88. DHN Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. DHN Swine Influenza Vaccines Product Portfolio Table 90. DHN Recent Development Table 91. Green Cross Veterinary Company Information Table 92. Green Cross Veterinary Business Overview Table 93. Green Cross Veterinary Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Green Cross Veterinary Swine Influenza Vaccines Product Portfolio Table 95. Green Cross Veterinary Recent Development Table 96. Hipra Company Information Table 97. Hipra Business Overview Table 98. Hipra Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Hipra Swine Influenza Vaccines Product Portfolio Table 100. Hipra Recent Development Table 101. MSD Animal Health (Merck) Company Information Table 102. MSD Animal Health (Merck) Business Overview Table 103. MSD Animal Health (Merck) Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. MSD Animal Health (Merck) Swine Influenza Vaccines Product Portfolio Table 105. MSD Animal Health (Merck) Recent Development Table 106. Ringpu Biology Company Information Table 107. Ringpu Biology Business Overview Table 108. Ringpu Biology Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Ringpu Biology Swine Influenza Vaccines Product Portfolio Table 110. Ringpu Biology Recent Development Table 111. Zoetis Company Information Table 112. Zoetis Business Overview Table 113. Zoetis Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Zoetis Swine Influenza Vaccines Product Portfolio Table 115. Zoetis Recent Development Table 116. Chengdu TECBOND Company Information Table 117. Chengdu TECBOND Business Overview Table 118. Chengdu TECBOND Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Chengdu TECBOND Swine Influenza Vaccines Product Portfolio Table 120. Chengdu TECBOND Recent Development Table 121. North America Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 122. North America Swine Influenza Vaccines Sales by Country (2021-2026) & (M Units) Table 123. North America Swine Influenza Vaccines Sales Market Share by Country (2021-2026) Table 124. North America Swine Influenza Vaccines Sales Forecast by Country (2027-2032) & (M Units) Table 125. North America Swine Influenza Vaccines Sales Market Share Forecast by Country (2027-2032) Table 126. North America Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Swine Influenza Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Swine Influenza Vaccines Market Share by Country (2021-2026) Table 129. North America Swine Influenza Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Swine Influenza Vaccines Market Share Forecast by Country (2027-2032) Table 131. Europe Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 132. Europe Swine Influenza Vaccines Sales by Country (2021-2026) & (M Units) Table 133. Europe Swine Influenza Vaccines Sales Market Share by Country (2021-2026) Table 134. Europe Swine Influenza Vaccines Sales Forecast by Country (2027-2032) & (M Units) Table 135. Europe Swine Influenza Vaccines Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Swine Influenza Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Swine Influenza Vaccines Market Share by Country (2021-2026) Table 139. Europe Swine Influenza Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Swine Influenza Vaccines Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Swine Influenza Vaccines Sales by Country (2021-2026) & (M Units) Table 143. Asia-Pacific Swine Influenza Vaccines Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Swine Influenza Vaccines Sales Forecast by Country (2027-2032) & (M Units) Table 145. Asia-Pacific Swine Influenza Vaccines Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Swine Influenza Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Swine Influenza Vaccines Market Share by Country (2021-2026) Table 149. Asia-Pacific Swine Influenza Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Swine Influenza Vaccines Market Share Forecast by Country (2027-2032) Table 151. Latin America Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 152. Latin America Swine Influenza Vaccines Sales by Country (2021-2026) & (M Units) Table 153. Latin America Swine Influenza Vaccines Sales Market Share by Country (2021-2026) Table 154. Latin America Swine Influenza Vaccines Sales Forecast by Country (2027-2032) & (M Units) Table 155. Latin America Swine Influenza Vaccines Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Swine Influenza Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Swine Influenza Vaccines Market Share by Country (2021-2026) Table 159. Latin America Swine Influenza Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Swine Influenza Vaccines Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Swine Influenza Vaccines Sales by Country (2021-2026) & (M Units) Table 163. Middle East and Africa Swine Influenza Vaccines Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Swine Influenza Vaccines Sales Forecast by Country (2027-2032) & (M Units) Table 165. Middle East and Africa Swine Influenza Vaccines Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Swine Influenza Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Swine Influenza Vaccines Market Share by Country (2021-2026) Table 169. Middle East and Africa Swine Influenza Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Swine Influenza Vaccines Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Swine Influenza Vaccines Distributors List Table 174. Swine Influenza Vaccines Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Swine Influenza Vaccines Image Figure 2. Global Swine Influenza Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Influenza Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Swine Influenza Vaccines Sales (2021-2032) & (M Units) Figure 5. Live Vaccines Image Figure 6. Global Live Vaccines Sales YoY Growth (2021-2032) & (M Units) Figure 7. Killed Vaccines Image Figure 8. Global Killed Vaccines Sales YoY Growth (2021-2032) & (M Units) Figure 9. Global Swine Influenza Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Swine Influenza Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Swine Influenza Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Swine Influenza Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Swine Influenza Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Swine Influenza Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Swine Influenza Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Swine Influenza Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Swine Influenza Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Swine Influenza Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Swine Influenza Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Swine Influenza Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Swine Influenza Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Commodity Pig Image Figure 24. Global Commodity Pig Sales YoY Growth (2021-2032) & (M Units) Figure 25. Breeding Pig Image Figure 26. Global Breeding Pig Sales YoY Growth (2021-2032) & (M Units) Figure 27. Global Swine Influenza Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Swine Influenza Vaccines Market Share by Application 2025 VS 2032 Figure 29. North America Swine Influenza Vaccines Sales Market Share in Volume by Application in 2025 Figure 30. North America Swine Influenza Vaccines Sales Market Share in Value by Application in 2025 Figure 31. Europe Swine Influenza Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. Europe Swine Influenza Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Swine Influenza Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Swine Influenza Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Latin America Swine Influenza Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Swine Influenza Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Swine Influenza Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Swine Influenza Vaccines Sales Market Share in Value by Application in 2025 Figure 39. North America Swine Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 40. North America Swine Influenza Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Swine Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Swine Influenza Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Swine Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 44. Europe Swine Influenza Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Swine Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Swine Influenza Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Swine Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 48. Asia-Pacific Swine Influenza Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Swine Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Swine Influenza Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Swine Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 52. Latin America Swine Influenza Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Swine Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Swine Influenza Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Swine Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 56. Middle East and Africa Swine Influenza Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Swine Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Swine Influenza Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Swine Influenza Vaccines Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Swine Influenza Vaccines Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Commodity Pig
  • Breeding Pig
Companies covered
  • Boehringer Ingelheim
  • CAHIC
  • Ceva
  • DHN
  • Green Cross Veterinary
  • Hipra
  • MSD Animal Health (Merck)
  • Ringpu Biology
  • Zoetis
  • Chengdu TECBOND

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Swine Influenza Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Swine Influenza Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Swine Influenza Vaccines Market by Type
  6. 1.3.1 Live Vaccines
  7. 1.3.2 Killed Vaccines
  8. 1.4 Global Swine Influenza Vaccines Market Size by Type
  9. 1.4.1 Global Swine Influenza Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Swine Influenza Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Swine Influenza Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Swine Influenza Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Swine Influenza Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Swine Influenza Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Swine Influenza Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Swine Influenza Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Swine Influenza Vaccines Industry Trends
  2. 2.2 Swine Influenza Vaccines Industry Drivers
  3. 2.3 Swine Influenza Vaccines Industry Opportunities and Challenges
  4. 2.4 Swine Influenza Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Swine Influenza Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Swine Influenza Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Swine Influenza Vaccines Price (2021-2026)
  4. 3.4 Global Swine Influenza Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Swine Influenza Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Swine Influenza Vaccines Company, Product Type & Application
  7. 3.7 Global Swine Influenza Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Swine Influenza Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Swine Influenza Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Swine Influenza Vaccines Tier 1, Tier 2, and Tier 3
4 Swine Influenza Vaccines Regional Status and Outlook
  1. 4.1 Global Swine Influenza Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Swine Influenza Vaccines Historic Market Size by Region
  3. 4.2.1 Global Swine Influenza Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Swine Influenza Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Swine Influenza Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Swine Influenza Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Swine Influenza Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Swine Influenza Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Swine Influenza Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Swine Influenza Vaccines by Application
  1. 5.1 Swine Influenza Vaccines Market by Application
  2. 5.1.1 Commodity Pig
  3. 5.1.2 Breeding Pig
  4. 5.2 Global Swine Influenza Vaccines Market Size by Application
  5. 5.2.1 Global Swine Influenza Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Swine Influenza Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Swine Influenza Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Swine Influenza Vaccines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Swine Influenza Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Swine Influenza Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Swine Influenza Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Swine Influenza Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Swine Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Swine Influenza Vaccines Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 CAHIC
  8. 6.2.1 CAHIC Company Information
  9. 6.2.2 CAHIC Business Overview
  10. 6.2.3 CAHIC Swine Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CAHIC Swine Influenza Vaccines Product Portfolio
  12. 6.2.5 CAHIC Recent Developments
  13. 6.3 Ceva
  14. 6.3.1 Ceva Company Information
  15. 6.3.2 Ceva Business Overview
  16. 6.3.3 Ceva Swine Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ceva Swine Influenza Vaccines Product Portfolio
  18. 6.3.5 Ceva Recent Developments
  19. 6.4 DHN
  20. 6.4.1 DHN Company Information
  21. 6.4.2 DHN Business Overview
  22. 6.4.3 DHN Swine Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 DHN Swine Influenza Vaccines Product Portfolio
  24. 6.4.5 DHN Recent Developments
  25. 6.5 Green Cross Veterinary
  26. 6.5.1 Green Cross Veterinary Company Information
  27. 6.5.2 Green Cross Veterinary Business Overview
  28. 6.5.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Green Cross Veterinary Swine Influenza Vaccines Product Portfolio
  30. 6.5.5 Green Cross Veterinary Recent Developments
  31. 6.6 Hipra
  32. 6.6.1 Hipra Company Information
  33. 6.6.2 Hipra Business Overview
  34. 6.6.3 Hipra Swine Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hipra Swine Influenza Vaccines Product Portfolio
  36. 6.6.5 Hipra Recent Developments
  37. 6.7 MSD Animal Health (Merck)
  38. 6.7.1 MSD Animal Health (Merck) Company Information
  39. 6.7.2 MSD Animal Health (Merck) Business Overview
  40. 6.7.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 MSD Animal Health (Merck) Swine Influenza Vaccines Product Portfolio
  42. 6.7.5 MSD Animal Health (Merck) Recent Developments
  43. 6.8 Ringpu Biology
  44. 6.8.1 Ringpu Biology Company Information
  45. 6.8.2 Ringpu Biology Business Overview
  46. 6.8.3 Ringpu Biology Swine Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Ringpu Biology Swine Influenza Vaccines Product Portfolio
  48. 6.8.5 Ringpu Biology Recent Developments
  49. 6.9 Zoetis
  50. 6.9.1 Zoetis Company Information
  51. 6.9.2 Zoetis Business Overview
  52. 6.9.3 Zoetis Swine Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Zoetis Swine Influenza Vaccines Product Portfolio
  54. 6.9.5 Zoetis Recent Developments
  55. 6.10 Chengdu TECBOND
  56. 6.10.1 Chengdu TECBOND Company Information
  57. 6.10.2 Chengdu TECBOND Business Overview
  58. 6.10.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Chengdu TECBOND Swine Influenza Vaccines Product Portfolio
  60. 6.10.5 Chengdu TECBOND Recent Developments
7 North America by Country
  1. 7.1 North America Swine Influenza Vaccines Sales by Country
  2. 7.1.1 North America Swine Influenza Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Swine Influenza Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Swine Influenza Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Swine Influenza Vaccines Market Size by Country
  6. 7.2.1 North America Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Swine Influenza Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Swine Influenza Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Swine Influenza Vaccines Sales by Country
  2. 8.1.1 Europe Swine Influenza Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Swine Influenza Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Swine Influenza Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Swine Influenza Vaccines Market Size by Country
  6. 8.2.1 Europe Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Swine Influenza Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Swine Influenza Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Swine Influenza Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Swine Influenza Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Swine Influenza Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Swine Influenza Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Swine Influenza Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Swine Influenza Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Swine Influenza Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Swine Influenza Vaccines Sales by Country
  2. 10.1.1 South America Swine Influenza Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Swine Influenza Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Swine Influenza Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Swine Influenza Vaccines Market Size by Country
  6. 10.2.1 South America Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Swine Influenza Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Swine Influenza Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Swine Influenza Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Swine Influenza Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Swine Influenza Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Swine Influenza Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Swine Influenza Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Swine Influenza Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Swine Influenza Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Swine Influenza Vaccines Value Chain Analysis
  2. 12.1.1 Swine Influenza Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Swine Influenza Vaccines Production Mode & Process
  7. 12.2 Swine Influenza Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Swine Influenza Vaccines Distributors
  10. 12.2.3 Swine Influenza Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst